Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis EZZ

Max Ratio

Dividend Yield

1.29 %

5Y Dividend Growth

0.00 %

Consecutive Years

2 years

5Y Average Payout Ratio

14.04 %

Dividend History EZZ

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 1.29 %
Consecutive Years 2
Forward Annual Dividend 0.020 AUD
Consistent Years 3
Dividend CAGR 3Y 98.13 %
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM 13.74 %
Dividend CAGR 10Y
Ex Dividend Date 11/24/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth EZZ

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin EZZ

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income EZZ

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM EZZ

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio EZZ

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

EZZ Life Science Holdings Ltd EZZ

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself EZZ

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 10.33
Forward PE
Enterprise Value Revenue 0.84
Price Sales TTM 1.09
Enterprise Value EBITDA 5.03
Price Book MRQ 2.72

EZZ Life Science Holdings Ltd Dividends: 1.29 % Yield, History, Payment Schedule

EZZ
Current price
1.55 AUD -0.099 AUD (-6.06%)
Last closed 1.62 AUD
ISIN AU0000130569
Sector Healthcare
Industry Biotechnology
Exchange Australian Securities Exchange
Capitalization 72 873 929 AUD
Yield for 12 month -41.29 %
1Y
3Y
5Y
10Y
15Y
EZZ
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+66 650 047 AUD

Last Year

+66 221 166 AUD

Current Quarter

+36 463 473 AUD

Last Quarter

+30 186 574 AUD

Current Year

+49 553 466 AUD

Last Year

+50 775 077 AUD

Current Quarter

+26 322 338 AUD

Last Quarter

+23 231 127 AUD
EBITDA 10 050 610 AUD
Operating Margin TTM 14.66 %
Price to Earnings 10.33
Return On Assets TTM 20.86 %
PEG Ratio
Return On Equity TTM 27.24 %
Wall Street Target Price 7.53 AUD
Revenue TTM 66 650 048 AUD
Book Value 0.59 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -18.20 %
Dividend Yield 1.29 %
Gross Profit TTM 49 553 468 AUD
Earnings per share 0.15 AUD
Diluted Eps TTM 0.15 AUD
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY -44.20 %
Profit Margin 10.06 %

Technical Indicators EZZ

For 52 Weeks

1.26 AUD 3.34 AUD
50 Day MA 2.46 AUD
Shares Short Prior Month
200 Day MA 2.05 AUD
Short Ratio
Shares Short
Short Percent